Risperidone stimulates food intake and induces body weight gain via the hypothalamic arcuate nucleus 5‐HT2c receptor—NPY pathway

AIMS: Many patients taking risperidone for the treatment of psychiatric disorders experience substantial body weight gain. Researchers have speculated that risperidone induces obesity by modulating central signals; however, the precise central mechanisms involved remain to be fully elucidated. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Xiao‐Qin, Zeng, Fan, Huang, Xu‐Feng, Yang, He‐Qin, Wang, Lan, Shi, Yan‐Chuan, Zhang, Zhi‐Hui, Lin, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163792/
https://www.ncbi.nlm.nih.gov/pubmed/31880085
http://dx.doi.org/10.1111/cns.13281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163792/
https://www.ncbi.nlm.nih.gov/pubmed/31880085
http://dx.doi.org/10.1111/cns.13281

Ejemplares similares